p53 mutations in malignant gliomas

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 4, 1998, Pages 303-308

  Li, Yu ^b   Millikan, Robert C ^b   Carozza, Susan ^c   Newman, Beth ^b   Liu, Edison ^d   Davis, Richard ^a   Miike, Rei ^a   Wrensch, Margaret ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b IL   (United States)

^c TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DNA, NEOPLASM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENES, P53; GLIOMA; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SAN FRANCISCO;

EID: 0031902729     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Central Brain Tumor Registry of the United States (CBTRUS) 1996 Annual Report Chicago: CBTRUS, 1997.
2. Kleihues, P., Soylemezoglu, F., Schauble, B., Scheithauer, B , and Burger, P. Histopathology, classification and grading of ghomas. Glia, 15: 211-221, 1995.
3. Parker, S , Tong, T., Bolden, S., and Wingo, P Cancer statistics, 1997. CA Cancer J. Clin , 47: 5-27, 1997
4. Ries, L. A. G., Miller, B., Hankey, B., Kosary, D., Harris, A , and Edwards, B K. (eds.). SEER Cancer Statistics Review, 1973-1991 NIH Pub No. 94-2789. Bethesda, MD National Cancer Institute, 1994.
5. Wrensch, M., Bondy, M L , Wiencke, J., and Yost, M Environmental risk factors for primary malignant brain tumors: a review. J. Neuro-oncol., 17: 47-64, 1993
6. Wrensch, M., Lee, M., Miike, R., Newman, B., Barger, G., Davis, R., Wiencke, J , and Neuhaus, J. Family and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol., 145: 581-593, 1997.
7. Inksip, P., Linet, M., and Heineman, E. Etiology of brain tumors in adults. Epidemiol. Rev , 17: 382-414, 1995.
8. Kyritsis, A., Bondy, M., Xiao, M., Berman, E., Cunningham, J., Lee, P., Levin, V., and Saya, H. Germline p53 gene mutations in subsets of glioma patients J. Natl. Cancer Inst , 86: 344-349, 1994.
9. Nigro, J , Baker, S., Presisinger, A., Hostetter, R , Cleary, K., Bigner, S , Davidson. N., Baylin, S., Devilee, P , Glover, T., Collins, F , Weston, A., Modali, R., Harris, C., and Vogelstein, B Mutations in the p53 gene occur in diverse human tumor types. Nature (Lond), 342: 705-708, 1989.
10. Greenblatt, M , Bennett, W., Hollstein, M , and Harris, C. Mutations in the p53 tumor suppressor gene clues to cancer etiology and molecular pathogenesis. Cancer Res., 54 4855-4878, 1994.
11. Koga, H , Zhang, S., Kumanishi, T., Washiyama, K , Ichikawa, T., Tanaka, R , and Mukawa, J. Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry. Acta Neuropathol., 87: 225-232, 1994.
12. Dalrymple, S., and Jenkins, R. Molecular genetics of astrocytomas and meningiomas. Curr. Opin. Neurol., 7: 477-484, 1994.
13. Kleihues, P., Aguzzi, A., and Ohgaki, H. Genetic and environmental factors in the etiology of human brain tumors. Toxicol. Lett (Amst.), 82/83: 601-605, 1995.
14. Ohgaki, H., Eibl, R., Schwab, M., Beichel, M., Mariani, L., Genring, M , Petersen, I., Holl, T , Wiestler, O., and Kleihues, P. Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog., 8: 74-80, 1993.
15. Von deimling, A., Eibl, R., Ohgaki, H., Louis, D., Von Ammon, K , Petersen, I , Kleihues, P., Chung, R., and Seizinger, B. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma Cancer Res., 52: 2987-2990, 1992.
16. Bogler, O., Huang, H-J , Kleihues, P., and Cavenee, W. The p53 gene and its role in human brain tumors. Glia, 15: 308-327, 1995.
17. Louis, D. A molecular genetic model of astrocytoma histopathology. Brain Pathol., 7: 755-764, 1997.
18. Sarkar, F., Kupsky, W., Li, Y-W., and Sreepathi, P. Analysis of p53 gene mutations in human gliomas by polymerase chain reaction-based single-strand conformation polymorphism and DNA sequencing. Diag. Mol. Pathol, 3: 2-8, 1994
19. Mashiyama, S., Murakami, Y., Yoshimoto, T., Sekiya, T , and Hayashi, K. Detection of p53 gene mutations in human brain tumors by single strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene, 6: 1313-1318, 1991.
20. Rasheed, B , McLendon, R., Herndon, J., Friedman, H., Friedman, A , Bigner, D , and Bigner, S. Alterations of the TP53 gene in human gliomas. Cancer Res, 54: 1324-1330, 1994
21. Cho, Y , Gorina, S , Jeffrey, P., and Pavletich, N. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mechanisms. Science (Washington DC), 265: 346-355, 1994
22. Hollstein, M., Sidransky, D., Vogelstein, B., Harris, C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
23. deFromentel, C., and Soussi, T. TPS3 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer,4: 1-15, 1992
24. Hayashi, K , and Yandell, D. How sensitive is PCR-SSCP? Hum Mutat., 2: 338-346, 1993.
25. Rosner, B. Fundamentals of Biostatistics. Boston PWS-Kent, 1990
26. SAS version 6.11. Cary, NC: SAS Institute, 1995
27. Hollstein, M., Shmoer, B., Greenblatt, M , Soussi, T , Hovig, E , Montesano, R., and Harris, C. Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res , 24: 141-146, 1996.
28. Von Deimling, A , Louis, D., and Wiestler, O Molecular pathways in the formation of gliomas Glia, 15: 328-338, 1995
29. Fults, D , Brockmeyer, D., Tullous, M., Pedone, C., and Cawthon, R. p53 mutation and loss of heterozygosity on chromosome 17 and 10 during human astrocytoma progression. Cancer Res., 52: 674-679, 1992.
30. Sidransky, D , Mikkelsen, T , Schwechheimer, K., Rosenblum, M., Cavenee, W , and Vogelstein, B Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature (Lond.). 355: 846-847, 1992.
31. Van Meir E , Kikuchi, T , Tada, M., Li, H., Diserens, A-C., Wojcik, B., Huang, H-H , Friedmann, T , de Tribolet, N , and Cavenee, W. Analysis of the p53 gene and its expression in human glioblastoma cells Cancer Res, 54: 649-652, 1994
32. Kovar, H., Auinger, A., Jug, G , Muller, T , and Pillwein, K. p53 mosaicism with an exon 8 germline mutation in the founder of a cancer-prone pedigree. Oncogene. 7: 2169-2173, 1992.
33. Frebourg, T , Kassel, J., Lam, K., Gryka, M., Barbier, N., Andersen, T., Borresen, A-L., and Friend, S. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein. Proc Natl. Acad. Sci. USA, 89 6413-6417, 1992.
34. Li, Y-J., Sanson, M., Hoang-Xuan, K., Delattre, J-Y., Poisson, M., Thomas, G , and Hamelin, R Incidence of germ-line p53 mutations in patients with gliomas Int. J. Cancer, 64: 383-387, 1995.
35. Felix, C., Brown, D., Mitsudomi, T., Ikagaki, N., Wong, A., Wasserman, R , Womer, R , and Biegel, J. Polymorphism at codon 36 of the p53 gene Oncogene, 9: 327-328, 1994
36. Cariello, N., Cui, L , Beroud, C , and Soussi, T. Database and software for the analysis of mutations in the human p53 gene. Cancer Res., 54, 4454-4460, 1994
37. Hongyo, T., Buzard, G., Palli, D , Weghorst, C., Amorosi, A , Galli, M., Caporaso, N., Fraumeni, J., and Rice, J Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Cancer Res., 55: 2665-2672, 1995.
38. Liu, W., Qian, C , and Francke, U. Silent mutation induces exon skipping of the fibrillin- 1 gene in Marfan syndrome Nat Genet., 16: 328-329, 1997.
39. Li, S , Park, W., Pyeritz, P , and Jabs, E. Effect of splicing of a silent FGR2 mutation in Crouzon syndrome. Nat Genet., 9: 232-233, 1995.
40. Berg, M., Guevara-Aguirre, J., Rosenbloom, A., Rosenfeld, R., and Francke, U. Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome Hum. Mutat., 1: 24-34, 1995
41. Strauss, B. Silent and multiple mutations in p53 and the question of the hypermutability of tumors. Carcinogenesis (Lond.), 18: 1445-1452, 1997.
42. Greenblatt, M , Grollman, A , and Harris, C. Deletions and insertions in the p53 tumor suppressor gene in human cancers: confirmation of the DNA polymerase slippage/misalignment model Cancer Res., 56, 2130-2136, 1996.
43. Casey, G., Lopez, M., Ramos, J , Plummer, S., Arboleta, M , Shaughnessy, M., Karlan, B., and Slamon, D. DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies Oncogens, 13: 1971-1981, 1996.
44. Biggs, P , Warren, W , Venitt, S , and Stratton, M Does a genotoxic carcinogen contribute to human breast cancer? The value of mutations spectra in unravelling the etiology of cancer Mutagenesis, 8 275-283, 1993.